If you are developing a novel pharmaceutical product or medical device that may be contaminated with both endotoxin and non-endotoxin pyrogens, you may need a broad-range pyrogen test. The traditional LAL assay detects endotoxins, but not non-endotoxin pyrogens. In contrast, our LumiMAT™ Pyrogen Detection Kit, which is a luminescent assay with reporter NOMO-1 cells based on the monocyte activation test (MAT), detects a wide range of both endotoxin and non-endotoxin pyrogens with high sensitivity, specificity, and reproducibility. Testing is rapid (completed within 5 hours) and requires only the addition of luminescent substrate to the plate after incubation. Learn more about our product here: https://loom.ly/iha92cQ #biopharma #endotoxintesting #endotoxins #MAT #LALreagents #pyrogentesting #LALassay
FUJIFILM Wako Pyrostar’s Post
More Relevant Posts
-
If you are developing a novel pharmaceutical product of medical device that may be contaminated with both endotoxin and non-endotoxin pyrogens, you may need a broad-range pyrogen test. However, the traditional LAL assay detects endotoxins, but not non-endotoxin pyrogens. In contrast, our LumiMAT™ Pyrogen Detection Kit, which is based on the monocyte activation test (MAT), can determine a wide range of endotoxin and non-endotoxin pyrogens with high sensitivity, specificity, and reproducibility. Learn more about the LumiMAT™ Pyrogen Detection Kit here: https://loom.ly/hznX6Mc #biopharma #endotoxintesting #pyrogens #MAT #LALassay #endotoxins
To view or add a comment, sign in
-
#DidYouKnow Scorpion venom, priced at $38,858,507.46 per gallon, is renowned as the world's most expensive liquid. Its rarity and potential medical applications make it highly valuable for research and pharmaceuticals, despite its deadly nature. www.tycoonstory.com #DidYouKnow #didyouknowfacts #amazingfacts #knowledgeispower #ScorpionVenom #MostExpensiveLiquid #MedicalResearch #Pharmaceuticals #Toxins #Peptides #BiomedicalScience #Innovation TYCOONSTORY DidYouKnow DIY
To view or add a comment, sign in
-
🚀 Continuing Your Pharma Education: Proton Pump Inhibitors Explained 🏥 Our latest article covers Proton Pump Inhibitors (PPIs), from their history and mechanism to indications and top formulas. A must-read for newcomers in the pharmaceutical industry! #ProtonPumpInhibitors #PharmaEducation #GERD #PepticUlcers #AcidSuppression #MedicalKnowledge #PharmaceuticalIndustry #HealthCare #MedicalRepresentative #PharmaColleagues #Health #MedicalStudent #HealthTips Read the full article now! 👇
To view or add a comment, sign in
-
🚀𝗣𝘂𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗟𝗶𝗺𝗶𝘁𝘀 𝗼𝗳 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻💊 Key takeaways from our upcoming webinar: • Role of particle size and zeta potential in pharmaceuticals • Fundamentals of Light Scattering (DLS & ELS) • Real-world case studies with BeNano Series And much more! Join Dr. John Miller and Zhibin Guo to elevate your pharmaceutical analysis expertise on Wednesday, September 25, 2024, 11:00 - 12:00 EDT. 👉Register now and secure your FREE spot: https://lnkd.in/g2VPuAm5 #Bettersize #BettersizeWebinar #pharmawebinar #pharmaceuticals #PharmaCharacterization #DrugDiscovery #DrugDevelopment #drugstability #drugformulations #nanomedicine
To view or add a comment, sign in
-
Hear Sascha Stave present a study that investigates patient preferences in atopic dermatitis treatment. Results show that safety is the top priority for patients, with many favoring treatments with fewer side effects, even if they take longer to show results. The study underscores the need for clinicians to emphasize safety in treatment discussions and for pharmaceutical companies to develop safer treatment options. 🔗 Read more about EADV 2024 here: https://lnkd.in/dvfjqe7f #AtopicDermatitis #Treatment #PatientPreferences
Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment
https://bpno.dk
To view or add a comment, sign in
-
The demand for efficient inhalation therapies is higher than ever. At Hovione we are focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes. To learn more about or work, do not miss the contribution of Eunice Costa, our R&D Director for Inhalation & Advanced Drug Delivery, in the latest Pharmaceutical Technology eBook – “Trends in Formulation”. In the article “Formulating Inhaled Medicines”, Eunice highlights key challenges, emphasizing the importance of excipient selection, device compatibility, and patient-centric design, all geared towards improving patient outcomes in respiratory treatments. 👉Read the article and explore the Trends in Formulation eBook here: https://lnkd.in/dqceBABn 👉 Connect with our experts at the Drug Delivery to the Lungs Conference (DDL) - Booth No.168. Schedule your meeting - https://lnkd.in/dYsxxduz Pharmaceutical Technology #inhalation #nasal #DPI #inhaler #respiratory #drugproduct #drugdelivery #drugdevelopment #formulation #analytical #cdmo #initforlife
To view or add a comment, sign in
-
Learn about innovative capping strategies to boost potency, cut costs, and expedite the production of your mRNA programs! Join us on March 27 together with Pharmaceutical Technology for an exciting webinar delving into the crucial role of 5’ cap structures in #mRNA stability and expression. https://lnkd.in/g2tJ3rWM
To view or add a comment, sign in
-
We're thrilled to invite you to our upcoming webinar: 'Benefits of Silicone-oil-free Syringe Systems.’ Our webinar will offer an in-depth look at how we have meticulously designed our prefilled syringe portfolio for ophthalmology to align with the rigorous standards of this specialized therapeutic field. In line with our commitment to excellence and the evolving landscape of drug technologies, we are proud to unveil our comprehensive prefilled silicone-oil-free syringe systems. Collaborating closely with our pharmaceutical partners, we're dedicated to advancing patient care and well-being. We have eliminated free silicone oil from the components of our prefilled syringe systems. This proactive measure not only mitigates the risk of drug interaction during storage but also minimizes potential post-injection risks to patients, ensuring unrivaled functionality in the market. Learn more about our speakers: Bernd Zeiß Zeiss and Maximilian Vogl Registration: https://lnkd.in/e6An8DF7 #innovatingforabetterlife #webinar #syringes #pharma #biotech #drugdelivery
To view or add a comment, sign in
-
Hear Sascha D. W. Stave present a study that investigates patient preferences in atopic dermatitis treatment. Results show that safety is the top priority for patients, with many favoring treatments with fewer side effects, even if they take longer to show results. The study underscores the need for clinicians to emphasize safety in treatment discussions and for pharmaceutical companies to develop safer treatment options. 🔗 Read more about EADV 2024 here: https://lnkd.in/dxiqK8DT #AtopicDermatitis #Treatment #PatientPreferences
Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment
https://bpno.no
To view or add a comment, sign in
1,000 followers